Stories

CEO Dave Ricks Shares Lilly's Principles of COVID-19 Antibody Therapy Pricing and Access

View Story

Updates: Lilly's Global COVID-19 Response

View Story

Lilly Statement Regarding NIH’s ACTIV-3 Clinical Trial

View Story

Lilly’s Commitment to Quality Manufacturing

View Story

Still image from CAR-approved video; employee consent is on file

Lilly Global Day of Service Goes Virtual and Remote to Improve Health, Education and Communities

View Story

Lilly Statement on the NIAID Decision to Pause Enrollment in ACTIV-3 Clinical Trial

View Story

What Does It Take to Manufacture Neutralizing Antibodies?

View Story

Lilly Creates Mobile Research Units to Reach Elderly Patients

View Story

Indiana eLearning Lab and College Football Team Up

View Story

How to Prevent the Next Pandemic: Antimicrobial Resistance

View Story